DYSTROPHIC EPIDERMOLYSIS BULLOSA
Clinical trials for DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy patch mends wounds in rare 'butterfly skin' disease
Disease control OngoingThis study tests a treatment called D-Fi, made from a patient's own skin cells that are genetically modified to produce a missing protein. It aims to improve wound healing in children and adults with dystrophic epidermolysis bullosa, a condition that causes fragile, blistering sk…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Castle Creek Biosciences, LLC. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New eye drops aim to soothe painful eye injuries in rare skin disease
Symptom relief OngoingThis study tests whether ELK-003 eye drops can safely ease eye symptoms in people with junctional or dystrophic epidermolysis bullosa (EB), a rare genetic condition causing fragile skin and frequent eye injuries. About 20 participants will first be observed, then use the drops 6 …
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1 • Sponsor: Fundación DEBRA Chile, Niños Piel de Cristal • Aim: Symptom relief
Last updated May 26, 2026 11:36 UTC